Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kadmon Holdings Inc. (KDMN)

3.76   -0.04 (-1.05%) 09-29 08:55
Open: 3.83 Pre. Close: 3.8
High: 3.85 Low: 3.7
Volume: 1,930,087 Market Cap: 643M
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company is headquartered in New York City, New York and currently employs 116 full-time employees. The firm is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases. Its product pipeline consists of KD025, Tesevatinib and KD034. The firm's other products include Ribasphere RibaPak, Ribasphere, Qsymia, Tetrabenazine and Valganciclovir. KD025 is an orally available, selective small molecule inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2), a molecular target in multiple autoimmune, fibrotic and neurodegenerative diseases. Tesevatinib is an oral tyrosine kinase inhibitor (TKI) designed to block key molecular drivers of tumor growth, metastases and drug resistance. KD034 is the Company's portfolio of enhanced formulations of trientine hydrochloride for the treatment of Wilson's disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.841 - 3.862 3.862 - 3.879
Low: 3.635 - 3.665 3.665 - 3.689
Close: 3.716 - 3.76 3.76 - 3.797

Technical analysis

as of: 2020-09-28 4:34:28 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.28     One year: 5.89
Support: Support1: 3.69    Support2: 3.07
Resistance: Resistance1: 4.52    Resistance2: 5.04
Pivot: 4.18
Moving Average: MA(5): 3.89     MA(20): 4.26
MA(100): 4.38     MA(250): 4.17
MACD: MACD(12,26): -0.12     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 9.54     %D(3): 10.52
RSI: RSI(14): 35.34
52-week: High: 5.50  Low: 2.30  Change(%): 46.3
Average Vol(K): 3-Month: 235014  10-Days: 272040

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
KDMN has closed above bottom band by 9.8%. Bollinger Bands are 20% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 28 Sep 2020
When is Kadmon Holdings, Inc. (KDMN) going to be good investment? - Marketing Sentinel

Mon, 28 Sep 2020
Kadmon Holdings Inc. (KDMN) upgraded Issued by Wall Street Gurus - The News Heater

Thu, 24 Sep 2020
Will Short Term Positive News Increase The Share Price Of Kadmon Holdings, Inc. (KDMN)? - Invest Million

Wed, 23 Sep 2020
Kadmon Holdings Inc. (KDMN) is 1.08% away from 50-day simple Moving Average despite all headwinds - News Daemon

Wed, 23 Sep 2020
Looking Closely at the Growth Curve for Kadmon Holdings Inc. (KDMN) - The News Heater

Tue, 22 Sep 2020
Is Kadmon Holdings Inc (KDMN) a Winner in the Biotechnology Industry? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 171
Shares Float (M) 139
% Held by Insiders 0.16
% Held by Institutions 83.14
Shares Short (K) 27,090
Shares Short P. Month (K) 28,420

Stock Financials

EPS -0.892
EPS Est This Year -1.550
EPS Est Next Year -1.750
Book Value (p.s.) 0.700
Profit Margin
Operating Margin -715.86
Return on Assets (ttm) -24.6
Return on Equity (ttm) -85.8
Qtrly Rev. Growth 853.8
Gross Profit (p.s.) 0.022
Sales Per Share 0.069
EBITDA (p.s.) -0.486
Qtrly Earnings Growth
Operating Cash Flow (M) -74
Levered Free Cash Flow (M) -38

Stock Valuations

PE Ratio -4.22
PEG Ratio
Price to Book value 5.37
Price to Sales 54.49
Price to Cash Flow -8.73

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.